| 1. | karmakid17 | |
| 2. | roseannhogan | |
| 3. | mpee3438 | |
| 4. | pharmaseise |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | pharmaseise 05/17/2018 Agree that data from today will keep this stock rising |
| 2. | mpee3438 01/23/2018 Waking up from a nap to see this, great |
| 3. | mpee3438 05/17/2018 Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy |
| 4. | roseannhogan 02/06/2018 Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program |
| 5. | karmakid17 03/29/2018 Filed $150 mln mixed securities shelf offering |
| 6. | karmakid17 02/28/2018 Gene Therapy Holds Out Hope for Diabetics |
| 7. | roseannhogan 01/23/2018 Stock Offering News |
| 8. | karmakid17 01/23/2018 Yep :( |
| 9. | karmakid17 01/26/2018 prices 5.75M share offering at $35 |
| 10. | roseannhogan 05/17/2018 Happy |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Audentes Therapeutics, Inc.
- BOLD
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.